/

Codexis, Inc.

CDXS US

CDXS USCodexis, Inc.

United States Composite

3.91

USD

+0.58

(+17.42%)

-1.12EPS Dil.

-3.49P/E

273.33MMarket Cap

Codexis, Inc.

CDXS

(United States Composite)

Recent

price

3.91

P/E

ratio

-3.49

div

yld

- -

ROIC.AI

Legends:

Stock price

1.97

Beta (1.0 Market)

% total return 05/03

Stock

S&P500

YTD

-30.07

- -

-87.20

- -

-86.00

- -

2008

2009

2010

2011

2012

2013

2014

2015

2016

2017

2018

2019

2020

2021

2022

2023

TTM

FRC

18.60

31.62

4.35

3.47

2.40

0.83

0.92

1.06

1.20

1.08

1.16

1.21

1.16

1.62

2.12

1.03

-16.63

-7.50

-0.35

-0.46

-0.84

-1.08

-0.50

-0.19

-0.21

-0.50

-0.21

-0.40

-0.33

-0.51

-1.12

-16.53

-7.43

-1.79

-0.31

-0.40

-0.63

0.00

-0.04

-0.07

-0.21

-0.32

-0.29

-0.34

-0.44

0.05

-0.84

- -

-51.33

-4.70

-4.83

-5.13

-5.72

-6.70

-6.97

-7.03

-7.08

-6.51

-6.11

-5.82

-5.70

-5.95

-6.40

-7.12

-49.39

-4.39

2.41

2.31

1.65

0.75

0.43

0.42

0.38

0.44

0.98

1.74

2.60

2.48

2.15

1.20

107

124

105

139

-87.11

-22.15

-6.65

-12.84

-34.56

-128.90

-54.13

-18.59

-17.54

-45.92

-18.64

-18.33

-34.64

-21.67

-22.88

-78.13

-45

-20

-9

-17

-31

-41

-19

-8

-9

-23

-11

-12

-24

-21

-34

-76

- -

-89.40

-24.47

-7.97

-13.36

-34.95

-129.39

-54.01

-18.13

-17.52

-45.97

-17.95

-17.43

-34.77

-20.31

-24.24

-108.69

159

129

114

- -

-129

-145

107

103

106

170

164

145

- -

Capital Structure

FRC

•

in mil. unless spec.

Jun'23

Sep'23

Dec'23

ST Debt

LT Borrowings

- -

LT Finance Leases

Preferred Equity and Hybrid Capital

- -

Shares Outstanding

Market Capitalization

195

132

213

Working Capital

FRC

•

in mil. unless spec.

Jun'23

Sep'23

Dec'23

Total Current Assets

120

103

Cash, Cash Equivalents & STI

Accounts Receivable, Net

Inventories

Total Current Liabilities

Payables & Accruals

ST Debt

Deferred Revenue

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years

5 years

1 year

Sales/Revenue/Turnover

11.79%

9.57%

-49.64%

Net Income, GAAP

-28.64%

-56.41%

-123.53%

Free Cash Flow

-NaN%

-433.97%

-2,000.00%

Total Cash Common Dividend

- -

Total Equity

18.46%

18.91%

-40.00%

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

2021

105

2022

139

2023

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

2021

-0.14

-0.07

0.03

-0.16

-0.33

2022

-0.13

-0.04

-0.15

-0.19

-0.51

2023

-0.34

-0.17

-0.50

-0.10

-1.12

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

2021

- -

2022

- -

2023

- -

Business: Codexis, Inc. discovers, develops, and sells enzymes and other proteins. The company operates through two segments, Performance Enzymes and Novel Biotherapeutics. It offers biocatalyst products and services. The company also provides biocatalyst screening and protein engineering services. In addition, it offers CodeEvolver, a technology platform, which helps in developing and delivering biocatalysts that perform chemical transformations and enhance the efficiency and productivity of manufacturing processes. The company's platform is also used for molecular biology and in vitro diagnostic enzymes. It has a collaboration agreement with Nestlé Health Science to develop CDX-7108 for the treatment of exocrine pancreatic insufficiency. The company sells its products to pharmaceutical manufacturers through its direct sales and business development force in the United States and Europe. The company was incorporated in 2002 and is headquartered in Redwood City, California.

Company News

Tipranks
5 days ago
Codexis (CDXS) Receives a Buy from Craig-Hallum
Yahoo
8 days ago
With 74% institutional ownership, Codexis, Inc. (NASDAQ:CDXS) is a favorite amongst the big guns
Tipranks
8 days ago
Codexis (CDXS) Gets a Buy from Piper Sandler
Yahoo
15 days ago
Codexis to Report First Quarter 2024 Financial Results on May 2
Yahoo
23 days ago
Codexis Appoints Carole Cobb, MBA, to Strategic Advisory Board
Yahoo
a month ago
Favourable Signals For Codexis: Numerous Insiders Acquired Stock

2008

2009

2010

2011

2012

2013

2014

2015

2016

2017

2018

2019

2020

2021

2022

2023

TTM

FRC

18.60

31.62

4.35

3.47

2.40

0.83

0.92

1.06

1.20

1.08

1.16

1.21

1.16

1.62

2.12

1.03

-16.63

-7.50

-0.35

-0.46

-0.84

-1.08

-0.50

-0.19

-0.21

-0.50

-0.21

-0.40

-0.33

-0.51

-1.12

-16.53

-7.43

-1.79

-0.31

-0.40

-0.63

0.00

-0.04

-0.07

-0.21

-0.32

-0.29

-0.34

-0.44

0.05

-0.84

- -

-51.33

-4.70

-4.83

-5.13

-5.72

-6.70

-6.97

-7.03

-7.08

-6.51

-6.11

-5.82

-5.70

-5.95

-6.40

-7.12

-49.39

-4.39

2.41

2.31

1.65

0.75

0.43

0.42

0.38

0.44

0.98

1.74

2.60

2.48

2.15

1.20

107

124

105

139

-87.11

-22.15

-6.65

-12.84

-34.56

-128.90

-54.13

-18.59

-17.54

-45.92

-18.64

-18.33

-34.64

-21.67

-22.88

-78.13

-45

-20

-9

-17

-31

-41

-19

-8

-9

-23

-11

-12

-24

-21

-34

-76

- -

-89.40

-24.47

-7.97

-13.36

-34.95

-129.39

-54.01

-18.13

-17.52

-45.97

-17.95

-17.43

-34.77

-20.31

-24.24

-108.69

159

129

114

- -

-129

-145

107

103

106

170

164

145

- -